BW Communities

Articles for Pharma

Dr Reddy's To Buy Eight Products In US For $350 Million

The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said

Read More
Govt Weighs Relaxing FDI Norms In Brownfield Pharma Companies

Government is considering a proposal to relax foreign direct investment norms in existing pharmaceutical companies with a view to attracting more overseas inflows

Read More
Mockery Of Corporate Governance: The Sun Pharma Way

Sun Pharma has not only violated the good corporate governance in terms of transparency but also consciously tried to make the investors believe that there is no plan to either divest assets or to cut jobs by strongly denying the then true media reports

Read More
Sun Pharma Enters Dermatology Segment To Expand Retail Offering

The world's fifth biggest generic drug maker launched a new dermatology product - Suncros - a sunscreen brand which was earlier available only as a branded prescription product

Read More
Turning The Spotlight On Quality Of Medical Devices

Capping the price of a device is counter-productive - it will halt research and innovation and won't benefit the patient; the cost of the device such as stent is a mere fraction of the total cost of the procedure required for its implantation

Read More
Sun Pharma Q4 Net Up 93 Per Cent On Exclusivity Sales In US, Low cost

Sun Pharma’s formulation sales in the United States at $580 million during the quarter grew 19 per cent over the last year

Read More
India Approves First Stem Cell-based Drug For Buerger's Disease

The drug controller general of India has granted limited approval to Stempeutics Research, a joint venture between drug maker Cipla and Manipal Group for manufacturing and marketing its stem cell based biological drug Stempeucel for the treatment of Buerger’s Disease

Read More
Sun Pharma Gets US Subpoena Over Generic Drugs Pricing

The DoJ's antitrust division has also asked Sun Pharma's US unit for documents related to employee and corporate records and communications with competitors

Read More
Dr Reddy's Acquires 6 OTC Brands From Ducere Of US

Dr Reddy's Laboratories said on Wednesday that it has acquired a range of consumer health or over-the-counter brands from the US-based Ducere Pharma Llc for an undisclosed sum

Read More
Analysts Cut Cipla 2017 Estimate After Weak Q4 Show

Cipla’s January-to-March quarter results were below the market expectation due to inventory write-offs or reductions, rationalisation of unviable geographies, higher research and development spends and regulatory costs

Read More

Subscribe to our newsletter to get updates on our latest news